In Q1 FY2026 (ended March 31, 2026), Cronos Group reported revenue of $45.2 million, up 40.1% year-over-year. Net income was $13.8 million, a significant improvement from a loss in the prior year, with diluted EPS of $0.04. Operating income improved to a loss of $1.8 million, narrowing 55.0% from the prior year. The company held $821.9 million in cash and $1.07 billion in equity, with no long-term debt.
•Revenue grew 40.1% YoY to $45.2 million.
•Net income of $13.8 million, up 124.6% YoY.
•Operating loss narrowed 55.0% to $1.8 million.
•Diluted EPS of $0.04, compared to $0.00 in prior year.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Cronos Group Inc., a cannabinoid company provides the cultivation, production, distribution, and marketing of cannabis products globally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Cronos Group Inc. is a cannabinoid company that cultivates, produces, distributes, and markets cannabis products globally. The company offers a range of products including dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures. These products are sold under well-known brand names such as Spinach, Lord Jones, Lit, and Peace Naturals. Cronos Group operates in the drug manufacturing sector, specifically focusing on specialty and generic cannabis-based pharmaceuticals and consumer goods. The company's operations span across multiple countries, with a primary focus on the Canadian and international cannabis markets.
Where is Cronos Group Inc. (CRON) listed and what currency is used?
Cronos Group Inc. is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol CRON. The company's stock is traded in US Dollars (USD). As a Canadian company listed on a US exchange, investors can purchase shares using US currency. The listing on NasdaqGM provides Cronos Group with access to a broad base of international investors and enhances its visibility in the global financial markets.
What sector and industry does Cronos Group Inc. (CRON) belong to?
Cronos Group Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This classification reflects the company's focus on producing and distributing cannabis-based products, which are considered specialty pharmaceuticals and consumer health items. As a specialty drug manufacturer, Cronos Group develops products that target specific medical and recreational needs, differentiating itself from traditional generic drug manufacturers. The industry includes companies that produce both prescription and over-the-counter cannabis products.
Where is Cronos Group Inc. (CRON) headquartered and what markets does it serve?
Cronos Group Inc. is headquartered in Stayner, Canada. The company serves global markets, with a strong presence in Canada and international regions. Its products are distributed under brands like Spinach, Lord Jones, Lit, and Peace Naturals, which are available in various countries where cannabis is legal for medical or adult use. The company's operations include cultivation, production, and distribution facilities, allowing it to serve both domestic and international customers. By leveraging its Canadian base, Cronos Group exports to markets such as the United States (where permitted), Europe, and other regions with evolving cannabis regulations.
What are the main product categories and brands of Cronos Group Inc. (CRON)?
Cronos Group Inc. offers a diverse portfolio of cannabis products including dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures. These products are marketed under several distinct brand names: Spinach, Lord Jones, Lit, and Peace Naturals. Spinach is known for its high-quality flower and pre-rolls, while Lord Jones specializes in premium CBD-infused products such as tinctures and topicals. Lit focuses on vaporizer cartridges and concentrates, and Peace Naturals offers a range of medical cannabis products. This multi-brand strategy allows Cronos Group to target different consumer segments, from recreational users to medical patients, across various product formats.